Cross-disciplinary skills

New

Level 1 -

The Legal Challenges of Starting a Biotech Company: How to Properly Draft and Negotiate Your Shareholders’ Agreement

Presentation

Why participate?

Compare the different legal structures and choose the one best suited to the company’s needs. Understand the key elements required to form a company and the procedures involved in doing so.

Training Context:

Entrepreneurship is a complex undertaking that involves numerous formalities and legal obligations, regardless of the sector. Choosing the right legal structure, preparing for incorporation, and navigating the required procedures can be overwhelming for aspiring entrepreneurs.
This training provides participants with the essential tools to handle the main legal challenges associated with starting a business.

Learning objectives

  • Distinguish between operating as a sole proprietorship or forming a company.
  • Understand the specific characteristics of different types of companies (civil and commercial).
  • Identify the necessary elements for forming a company.
  • Understand how to draft company bylaws (articles of association).
  • Learn about key clauses that may be included in a shareholders’ agreement.
  • Anticipate the steps required to set up a company.

Teaching methods

Interactive Teaching, Case Studies, Experience Sharing

Audience

Entrepreneurs, future entrepreneurs, or anyone involved in the creation of a company.

Prerequisites

No prior legal knowledge is required.
This training is open to anyone who deals with corporate law concepts in their day-to-day activities or who is likely to encounter them as part of an entrepreneurial venture.

Duration

Half-day, 3.5 hours

Price

375 € HT (Public)
300 € HT (Membre)
150 € HT (Académique)

Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.

Trainers

Catalogue de formations-MabDesign-2023.pdf (2)

Alexandra

Carrel

Founding partner
MCE Carrel

Rating

There is no rating available because this training session was never carried out.

The benefits of our courses

  • Personalized support
  • Skills assessment
  • Certificate of completion
  • Training quality evaluation
  • Accessible to people with disabilities (please contact us)

How to access and deadlines

Registering online or by e-mail is a pre-registration. We will process your request within one week:

  • Contact by e-mail or telephone
  • Sending of administrative and educational documents: training agreement, training programme and positioning questionnaire.

Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.

When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.

For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr

Jean-Roch Fabreguettes

MEARY

Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris

Jean-Roch Fabreguettes est un spécialiste de la recherche translationnelle et des phases précoces de développement clinique des médicaments de thérapie innovantes (MTI). Pharmacien, titulaire d’un doctorat de l’Université de Montpellier 1, il a travaillé plus de 25 ans dans le domaine et a contribué, pour des équipes académiques comme pour des start-ups, à la réalisation de plus de 30 programmes de recherche sur différents types de MTI : thérapie génique in vivo ou ex vivo, thérapie cellulaire, ingénierie tissulaire… Il est actuellement Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris. Le centre MEARY est une plateforme de l’Assistance Publique – Hôpitaux de Paris (AP-HP), dédiée à la fabrication de médicament de thérapie innovante expérimentaux. Laboratoire membre de l’ISCT, il est autorisé par l’ANSM et dispose d’un certificat GMP. A ce titre Jean-Roch Fabreguettes est impliqué dans le développement clinique et la fabrication de nombreux MTI : CAR-T cells, lymphocytes T régulateurs, cellules stromales mésenchymateuses…

Précédemment, Jean-Roch Fabreguettes a été expert Qualité (CMC) auprès de l’ANSM durant 9 ans et a conseillé différentes sociétés de biotechnologies. Il est un intervenant régulier pour l’Université Paris Cité et un membre actif de l’ISCT et de réseaux nationaux et internationaux sur les MTI (UNI-TC, Join4ATMP).